TechnofoundersTechnofounders
Invest
All insights
Interview10 min read

Between Asia and MedTech: the unconventional journey of Delphine, CEO of Stimuli Technology

How a former Amazon and Rocket Internet executive turned her entrepreneurial experience into a MedTech success: Delphine does us the honour of sharing some of the secrets behind her success, with humility and authenticity!

A path to healthcare forged by experience

Delphine’s route to MedTech was not mapped out in advance. After working at Rocket Internet in Asia and then Amazon, it was the RemplaFrance venture that led her to the healthcare sector. This platform connecting healthcare professionals quickly expanded to include bespoke software solutions, notably for the Vivalto group.

The idea for RemplaFrance came about almost by chance, during a cruise with friends who were newly qualified doctors. “The first evening, I remember, we got them talking all night about their difficulties finding locums. Mathilde and I were completely hooked.” This natural curiosity and ability to identify unmet needs would prove to be major assets later on. A few years later, the acquisition of RemplaFrance by the Adecco group sealed Delphine’s first entrepreneurial success.

Above all, this first success in the healthcare ecosystem showed her the concrete impact a technological solution can have: helping towns recruit doctors, supporting practitioners in handing over their patient base. And that impact turns out to be Delphine’s main quest today!

The art of leading without mastering everything

When Delphine joined Stimuli at the end of 2021, she showed a humility that is rare in the sector: “I have to tell you, I learned everything. I knew nothing about medical devices, nothing about product, nothing about regulatory affairs.” This candour actually conceals a formidable strategy: surround yourself with the right skills and focus on your strengths.

“For me, you need two key people in this type of organisation: technical and regulatory. I am not key, I am easily replaceable,” she says. This outlook shows a managerial maturity in which ego gives way to collective effectiveness.

Her management style rests on two pillars: total transparency (all employees have real-time access to sales figures) and human closeness. An approach that is bearing fruit: when she moved to Singapore, the team’s few legitimate doubts were quickly dispelled by the effectiveness of the organisation she had put in place and by this complete transparency.

About Stimuli Technology

Stimuli Technology embodies the spirit of French MedTech: technological innovation, close collaboration with healthcare professionals, and the concrete roll-out of a device that is effective, safe, reimbursed and accessible, improving the quality of life of patients suffering from overactive bladder.

Tensi+: an innovative medical device

  • Tensi+ is a class IIa medical device under the new MDR regulation, dedicated to treating idiopathic or neurogenic overactive bladder. Stimuli Technology is ISO 13485 certified (the standard for medical device manufacturers).
  • It is based on transcutaneous stimulation of the posterior tibial nerve (TENS), via two electrodes placed on the inside of the ankle.
  • Recommended use: 20 minutes a day for 12 weeks, with first effects sometimes felt after 6 weeks and a marked improvement after 3 months (proven efficacy in around 67% of users within 3 months).

Roll-out and outlook

  • Already present in France and in many European countries, Stimuli Technology is rapidly expanding the availability of Tensi+ worldwide.
  • Recent clinical publications, including a prospective multicentre post-marketing study published in 2024, reinforce the device’s scientific and clinical validity.

A distinctive organisational model

Running a French company from Singapore might seem a handicap. Delphine has turned it into a competitive advantage. “I think we are even more efficient because I feel like I’m working a double shift. I get up, I’m fully loaded, I have lots of topics piled up. I can deal with things really fast while you are asleep in France.”

This unusual set-up does raise questions among investors. “How does this kind of organisation work?” she is regularly asked. Her answer is pragmatic: after two and a half years, the results speak for themselves. The team is motivated, targets are met, and efficiency is there.

An SME’s financial approach in a startup world

“I have always been very averse to costs and expenses. It is so hard to bring in a euro and so easy to let one go.”

Delphine Agullo, CEO of Stimuli Technology

Unlike many tech entrepreneurs, Delphine applies a management philosophy inherited from the traditional SME.

This financial prudence, which she fully embraces (“I think like an SME, not a startup”), is proving particularly relevant in the current context of tighter credit and difficulty securing funding rounds. Stimuli reached profitability without raising astronomical sums, proving that controlled growth can be more sustainable than expansion at any cost.

Her favourite management indicators reflect this obsession with control: “My sales, 15 times a day” and “the bank account”. Two simple but essential metrics that she follows religiously from her phone: revenue and cash.

Technical challenges: learning from mistakes

The journey has not been without pitfalls. Stimuli experienced major problems with the first version of its medical device. “It was a critical moment for the company,” Delphine admits. The mistake? Trusting without asking enough questions in a field she had not (yet) sufficiently mastered.

This painful experience, which she nevertheless handled masterfully, led her to develop an even more rigorous approach: understand without claiming to be an expert, ask the right questions and, above all, surround yourself with the right technical and regulatory skills.

€1.3Min revenue in the first year
67%proven efficacy within 3 months

Conversely, what pleasantly surprised her was the market’s reception: “In the first year, we made one point three million in revenue. We had no expectations, but we found that pretty crazy.” Here again, the result of an aligned vision, an experienced and properly sized sales team, and daily determination to solve production and distribution problems.

The TF ecosystem: the importance of external support

One often underestimated aspect of entrepreneurial success is the quality of the support received. Delphine stresses the crucial contribution of the Technofounders ecosystem, in particular Nicolas Barbier (Operating Partner at Technofounders), whom she regards as “her CFO”.

“The complete opposite of my previous experience… At RemplaFrance, it really was just the two of us alone in our boat. Limited means, making do. Here, whenever I need it, I have enormous backing.”

This smart outsourcing of certain skills (finance, legal) makes it possible to benefit from high-level expertise without bearing the fixed costs of a full in-house team.

Vision and ambitions: heading for the United States

For Stimuli, the strategy is clear: “Obtain marketing authorisation in the US within two years”, followed by integration into a more mature medtech company to consolidate its portfolio. Delphine makes no secret of her ambitions: if the opportunity arises with a US player, she would be ready to relocate to the United States.

This international vision rests on a strong conviction: “My dream would be for it to be with one of the players we are already constantly talking to.” An approach that favours relationships built over time rather than purely financial opportunities.

Advice from a CEO with a proven track record

Asked about the pitfalls young entrepreneurs should avoid, Delphine is direct: “Really, costs, costs, costs. We could perhaps have had many more people, but because we were not sitting on a pile of gold, it shaped us.”

Her philosophy: do not anticipate growth, prove it first. “First you prove there is commercial growth, then you commit to the costs.” An approach that may seem conservative but is paying off in an uncertain economic environment.

Work-life balance: sport as a safety valve

Despite a busy schedule and two children, Delphine has managed to create her own rituals. “I try to do sport almost every morning.” A radical change from her life in Paris, which illustrates her adaptability.

“Here, my thing is running. I would love to run the Angkor Wat half-marathon in Cambodia.” Personal goals that fuel her professional energy.

Conclusion: authenticity as a strength

What is striking about Delphine is her authenticity. She owns her technical gaps, puts her team before herself and does not hide her moments of doubt. This humility, far from being a weakness, becomes her greatest strength.

“Today, this is my best professional experience,” she says. A success that owes as much to her ability to unite a team as to her rigorous management of the company’s fundamentals.

In a startup ecosystem often marked by ego and one-upmanship, Delphine embodies a new generation of entrepreneurs: pragmatic, human and obsessed with the real impact of what she does. An inspiring model for anyone seeking to build a lasting company in a demanding sector like MedTech.